Full Press Release Details
argenx to Present at 40th Annual J.P. Morgan Healthcare Conference.
ARGX
argenx to Present at 40th Annual J.P. Morgan Healthcare Conference
Key Takeaway: argenx to Present at 40th Annual J.P. Morgan Healthcare Conference
Price reaction · baseline $350.19 (2021-12-31 close) · 1 other ARGX headline(s) in the window, move may be shared
day 0 close
+0.2%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+36%
120-day peak, hindsight
Typical move
4.7%
average across 12 past catalysts
Lead asset
Empasiprubart
Phase 2 · AChR-Ab Seropositive Generalized Myasthenia Gravis